Insiders Johnson & Johnson Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 02:05:16 2024-06-14 EDT			5-day change	1st Jan Change
12.9 ^EUR	+1.57%		+0.78%	-5.84%

06-15	Johnson & Johnson Announces Late-Breaking Results Show nipocalimab Significantly Improves Sjögren's Disease Activity in A Phase 2 Study	CI
06-14	EU regulator mandates label updates on CAR-T cancer therapies	RE

Valneva Names New Chief Scientific Officer	05-21	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	04-16	MT
Clearside Biomedical Names Victor Chong Chief Medical Officer	03-18	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	03-13	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	02-05	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	01-23	MT
Johnson & Johnson Names Eugene Woods as Board Member	11-30	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	11-30	CI
Johnson & Johnson Announces Executive Changes	23-10-23	CI
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	23-08-31	MT
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	23-07-31	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	23-07-20	MT
Idorsia's Commercial Chief to Step Down	23-05-30	MT
Nyxoah Appoints Chief Commercial Officer	23-05-11	MT
Johnson & Johnson Announces the Retirement of Ian E. L. Davis as Director	23-04-03	CI
STAAR Surgical Appoints Warren Foust as Chief Operating Officer	23-03-29	MT
Insider Sell: Johnson & Johnson	23-03-08	MT
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to Its Board of Directors	23-02-14	CI

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm